Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;5(6):496-502.
Epub 2012 Jul 29.

Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6

Affiliations

Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6

Vikas Mehta et al. Int J Clin Exp Pathol. 2012.

Abstract

Background: Biopsy Gleason score (bGS) remains an important prognostic indicator for adverse outcomes in Prostate Cancer (PCA). In the light of recent studies purporting difference in prognostic outcomes for the subgroups of GS7 group (primary Gleason pattern 4 vs. 3), upgrading of a bGS of 6 to a GS≥7 has serious implications. We sought to identify pre-operative factors associated with upgrading in a cohort of GS6 patients who underwent prostatectomy.

Design: We identified 281 cases of GS6 PCA on biopsy with subsequent prostatectomies. Using data on pre-operative variables (age, PSA, biopsy pathology parameters), logistic regression models (LRM) were developed to identify factors that could be used to predict upgrading to GS≥7 on subsequent prostatectomy. A decision tree (DT) was constructed.

Results: 92 of 281 cases (32.7%) were upgraded on subsequent prostatectomy. LRM identified a model with two variables with statistically significant ability to predict upgrading, including pre-biopsy PSA (Odds Ratio 8.66; 2.03-37.49, 95% CI) and highest percentage of cancer at any single biopsy site (Odds Ratio 1.03, 1.01-1.05, 95% CI). This two-parameter model yielded an area under curve of 0.67. The decision tree was constructed using only 3 leave nodes; with a test set classification accuracy of 70%.

Conclusions: A simplistic model using clinical and biopsy data is able to predict the likelihood of upgrading of GS with an acceptable level of certainty. External validation of these findings along with development of a nomogram will aid in better stratifying the cohort of low risk patients as based on the GS.

Keywords: Carcinoma; binary recursive partitioning; prostate/pathology/predictive modeling; statistical techniques/logistic regression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Decision tree analyses using prebiopsy PSA and hPCA. Binary cutpoints derived using this analyses are illustrated. The tree was constructed using 66% of the data for training and the remaining 34% for testing. Using only 3 leave nodes, the tree obtained a test set classification accuracy of 70%.

Similar articles

Cited by

References

    1. King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. International journal of radiation oncology, biology, physics. 2004;59:386–391. - PubMed
    1. King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications. International journal of cancer. Journal international du cancer. 2000;90:305–311. - PubMed
    1. Cam K, Yucel S, Turkeri L, Akdas A. Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens. International journal of urology : official journal of the Japanese Urological Association. 2002;9:257–260. - PubMed
    1. King CR, Long JP. Prostate biopsy grading errors: a sampling problem? International journal of cancer. Journal international du cancer. 2000;90:326–330. - PubMed
    1. Mian BM, Lehr DJ, Moore CK, Fisher HA, Kaufman RP Jr, Ross JS, Jennings TA, Nazeer T. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology. 2006;67:379–383. - PubMed

MeSH terms

Substances